ArticleBMJ open2020
Effectiveness of mass testing for control of COVID-19: a systematic review protocol.
Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- The Utility of Cognitive Screening in Asian Patients With Heart Failure: A Systematic Review.Frontiers in psychiatry · 2022Pooled it
- Effectiveness of hospital clowns for symptom management in paediatrics: systematic review of randomised and non-randomised controlled trials.BMJ (Clinical research ed.) · 2020Pooled it
- Effectiveness, Safety, and Immunogenicity of a Second COVID-19 Vaccine Booster in the Elderly: A Systematic Review and Meta-Analysis Protocol.Health science reports · 2026Article
- Article
- Innovative public strategies in response to COVID-19: A review of practices from China.Health care science · 2024Review
- Optimizing the detection of emerging infections using mobility-based spatial sampling.International journal of applied earth observation and geoinformation : ITC journal · 2024Article
- Effects on communication due to face mask use: an integrative review.Revista brasileira de enfermagem · 2023Review
- COVID-19 lateral flow test image classification using deep CNN and StyleGAN2.Frontiers in artificial intelligence · 2023Article
- Challenges and difficulties faced in low- and middle-income countries during COVID-19.Health policy OPEN · 2022Article
- Panorama of COVID-19, risk perception and vaccine confidence in São Paulo State population, Southeast Brazil.Health & social care in the community · 2022Article
- COVID-19 Mortality in Public Hospitals in a Brazilian State: An Analysis of the Three Waves of the Pandemic.International journal of environmental research and public health · 2022Observational
- Analysis of Survival of Patients Hospitalized with COVID-19 in Espírito Santo, Brazil.International journal of environmental research and public health · 2022Article
- Pasteurization, storage conditions and viral concentration methods influence RT-qPCR detection of SARS-CoV-2 RNA in wastewater.The Science of the total environment · 2022Article
- The impact of lockdowns during the COVID-19 pandemic on work-related accidents in Austria in 2020.Wiener klinische Wochenschrift · 2022Article
- Assessment of COVID-19 Molecular Testing Capacity in Jordan: A Cross-Sectional Study at the Country Level.Diagnostics (Basel, Switzerland) · 2022Article
- Optical imaging spectroscopy for rapid, primary screening of SARS-CoV-2: a proof of concept.Scientific reports · 2022Article
- How do we engage people in testing for COVID-19? A rapid qualitative evaluation of a testing programme in schools, GP surgeries and a university.BMC public health · 2022Article
- The challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in low-middle income countries and possible cost-effective measures in resource-limited settings.Globalization and health · 2022Review
- Cross-species virus transmission and its pandemic potential.Bulletin of the National Research Centre · 2022Review
- Discourse on COVID-19 Mass Testing vs. Rapid Testing Processing.Frontiers in public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSince March 2020, when the COVID-19 outbreak has been deemed a pandemic by the WHO, the SARS-CoV-2 spreading has been the focus of attention of scientists, authorities, public health agencies and communities around the world. One of the great concerns and challenges, mainly in low-income and middle-income countries, is the identification and monitoring of COVID-19 cases. The large-scale availability of testing is a fundamental aspect of COVID-19 control, but it is currently the biggest challenge faced by many countries around the world. We aimed to synthesise and critically evaluate the scientific evidence on the influence of the testing capacity for symptomatic individuals in the control of COVID-19. METHODS AND ANALYSIS: A systematic review will be conducted in eight databases, such as Medical Literature Analysis and Retrieval System Online, ISI-of-Knowledge, Cochrane Central Register of Controlled Trials, Embase, SCOPUS, Latin American and Caribbean Health Sciences Literature, PsycINFO and Chinese National Knowledge Infrastructure, from inception to 30 July 2020. No restriction regarding the language, publication date or setting will be employed. Primary outcomes will include the sensitivity as well as the specificity of the tests for COVID-19. Study selection will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist. Methodological assessment of the studies will be evaluated by the Cochrane Risk-of-Bias tool for randomised controlled trials, the MINORS for non-randomised studies and the Newcastle-Ottawa Scale for cohort or case-control studies. Findings will be structured according to the test type and target population characteristics and focused on the primary outcomes (sensitivity and specificity). Moreover, if sufficient data are available, a meta-analysis will be performed. Pooled standardised mean differences and 95% CIs will be calculated. Heterogeneity between the studies will be determined by I ETHICS AND DISSEMINATION: Ethical approval is not required. The results will be disseminated widely via peer-reviewed publication and presentations at conferences related to this field. PROSPERO REGISTRATION NUMBER: CRD42020182724.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.